Diagnosis

MOLTEK FDG (Fluorodeoxyglucose - 18F) 

It is a radiopharmaceutical used in the medical imaging modality positron emission tomography (PET). The uptake of 18F-FDG by tissues is a marker for the tissue uptake of glucose, which in turn is closely correlated with certain types of tissue metabolism.
Oncology: It is utilized for cancer patients during their diagnosis process and investgation of stages during treatment.
Cardiyology: Before surgical operation, it is used in order to identify metabolism of myocardium of patients who has anomalous originated left coronary artery

Norology: It is used in order to differantiate Alzheimer demantia from others. Indication of epileptogenic agents through interictal glucose hypometabolism.
 

68Ge/68Ga Generator 

Cyclotron-independent production of the positron emitter 68Gallium
We are supplying Eckert & Ziegler Isotope's pharmaceutical grade GalliaPharm for clinical use and Chemical Grade IGG100 generators for research and development are safe and reliable sources of Gallium-68 independent of the cyclotron.
This generator is designed to minimize both 68Ge breakthrough and metal impurities in the eluate. The ready-to-use generator is availaible in the activities 10 mCi, 20 mCi, 30mCi, 40 mCi, 50mCi and 65 mCi.
Magistrally produced Ga-68 peptides which are PSMA, DOTATATE or FAPI  are used as diagnostic agents in PET/CT.

Ga 68 PSMA is a radioactive PET/CT imaging agent for using the diagnosis of Prostate cancer. It is indicated for the diagnosis of prostate cancer, prostate cancer metastasis, and prostate cancer recurrence.
Once administered via injection, Ga 68 PSMA binds to PSMA, which is an important pharmacologic target for prostate cancer imaging because prostate cancer cells usually contain elevated levels of the antigen. 
As a radioactive agent that emits positrons, Ga 68 PSMA can be imaged by PET to indicate the presence of PSMA-positive prostate cancer lesions in the tissues of the body.
Ga-68 DOTATATE is used for imaging neuroendocrine tumors. DOTATATE is a peptide that can bind to receptors on the surface of neuroendocrine tumors. DOTATATE labeled with gallium-68, PET-CT imaging detects 90% of the tissues containing tumor cells.

COLD KITS
MAG-3 (NephroMAG 0.2 mg radiopharmaceutical preparation kit)
Active ingredient : Mertiatide (mercaptoacetyltriglycine)
Indications :  
This medicinal product is for diagnostic use only. The radiopharmaceutical product “technetium (99mTc) mertiatide” obtained after reconstitution and labeling with sodium pertechnetate (99mTc) solution is used for the evaluation of nephrological and urological disorders, especially kidney function, morphology and perfusion, and for the characterization of urine output.

PoltechMIBI (radiopharmaceutical kit for preparation of 99mTc-MIBI)
Active Ingredient: 1.0 mg [tetrakis(2-methoxy-2-methylpropyl-1-isocyanide) copper (1+)] tetrafluoroborate
Indications : 
Cardiology: It is indicated in the diagnosis and follow-up of ischemic heart disease / infarction with myocardial perfusion scintigraphy, and in the evaluation of left ventricular functions and wall movements. It is not indicated for staging of myocardial infarction.
Oncology: In the diagnosis and staging of malignant tumors with whole body scintigraphic imaging,
Endocrinology:  Diagnosis and location of parathyroid adenoma / hyperplasia with parathyroid scintigraphy in hyperparathyroid cases